This paper is in the following e-collection/theme issue:

Longitudinal and Cohort Studies in Public Health (413) Ophthalmology (68) Diabetes (263) Diabetic Retinopathy (18) Secondary Use of Clinical Data for Research and Surveillance (475) Cost-Effectiveness and Economics (356)

Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/56741, first published .
Patient-Centered Economic Burden of Diabetic Macular Edema: Retrospective Cohort Study

Patient-Centered Economic Burden of Diabetic Macular Edema: Retrospective Cohort Study

Patient-Centered Economic Burden of Diabetic Macular Edema: Retrospective Cohort Study

Authors of this article:

Kyungseon Choi1, 2 Author Orcid Image ;   Sang Jun Park3 Author Orcid Image ;   Hyuna Yoon1, 2 Author Orcid Image ;   Seoyoon Choi3 Author Orcid Image ;   Yongseok Mun4 Author Orcid Image ;   Seok Kim5 Author Orcid Image ;   Sooyoung Yoo5 Author Orcid Image ;   Se Joon Woo3 Author Orcid Image ;   Kyu Hyung Park6 Author Orcid Image ;   Junghyun Na1, 2 Author Orcid Image ;   Hae Sun Suh1, 2, 7 Author Orcid Image
Article Authors Cited by (9) Tweetations Metrics

Journals

  1. Janco L, Stefanickova J, Busanyova B, Sustykevicova Z, Pavlovicova G, Kusenda P, Branikova L, Mattova J, Sedlakova A, Javorska L, Popovcova M, Hurcikova M, Minova M, Majtanova N, Kolar P. Economic Burden of Age-Related Macular Degeneration and Diabetic Macular Edema in Slovakia: a Cost-of-illness Analysis. Bratislava Medical Journal 2025;126(4):544 View
  2. Kang H, Park S. Standard Vocabulary in Ophthalmology: A Comprehensive Review Centered on SNOMED CT. Journal of Retina 2025;10(1):1 View
  3. Kumar D, Gupta V, Tanwar R, Jaiswal N. Revolutionizing Diabetic Macular Edema Treatment: FDA Approval of Susvimo. SN Comprehensive Clinical Medicine 2025;7(1) View
  4. Salcedo-Villanueva G, Garcia-Sánchez G, Palacio-Pastrana C, Gascón-Guzmán G, Moreno-Andrade A, Olvera-Montaño O, Muñoz-Villegas P. One-year results of visual response following intravitreal novel anti-VEGF injection for diabetic macular edema in a Latino population. International Journal of Retina and Vitreous 2025;11(1) View
  5. Culbreth R, Mazer-Amirshahi M, Mycyk M, Falise A, Brent J, Aldy K, Wax P. Patient Centered Outcomes Research in Medical Toxicology. Journal of Medical Toxicology 2025;21(4):414 View
  6. Brown D, Wolf S, Veselovsky M, Veith M, Papp A, Mange S, Mondal L, Romanczak D, Janco L, Chauhan R, Romanowska-Dixon B, Eremina A, Dusova J, Sagong M, Kim S, Bae Y, Kim S, Bae Y, Son D, Kang H, Choi S, Stanga P. Long-Term Efficacy and Safety of CT-P42 in Patients with Diabetic Macular Edema: 52-Week Results from a Phase 3 Randomized Clinical Trial. Ophthalmology and Therapy 2025;14(11):2769 View
  7. Muayad J, Tukur H, Loya A, Chauhan M, Hussain Z, Lee A, Dahr S. Nationwide Analysis of Progressive Kidney Function Decline and Diabetic Macular Edema in Type 2 Diabetes. Ophthalmology Science 2026;6(1):100945 View
  8. Liu Z, Zheng X, Li H. Recent advances in the study of Conbercept for diabetic macular edema. International Journal of Retina and Vitreous 2025;11(1) View
  9. Mal W, Al-Abri M, Al Fadhil N, Jaju S, Al-Riyami A. Short-term efficacy and safety of intravitreal brolucizumab in diabetic macular edema: A retrospective interventional study. Oman Journal of Ophthalmology 2025;18(3):303 View